NGNE Neurogene Inc.: institutional ownership and insider trading
122 funds reported holding $563M of Neurogene Inc. in their latest 13F filings; in Q2 2026 funds net bought $8.60M, with 20 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $1.13M on the open market.
Famous investors holding NGNE
- Ken Griffin (Citadel Advisors): $13.7M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.34M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $642K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $308K, 0.0% of the portfolio
Largest institutional holders of NGNE
- Samsara BioCapital, LLC — $54.0M
- Casdin Capital, LLC — $48.6M
- Redmile Group, LLC — $44.4M
- RTW INVESTMENTS, LP — $42.8M
- EcoR1 Capital, LLC — $40.0M
- BlackRock, Inc. (BLK) — $33.3M
- BAKER BROS. ADVISORS LP — $31.2M
- BALYASNY ASSET MANAGEMENT L.P. — $25.7M
- Trails Edge Capital Partners, LP — $22.5M
- TORONTO DOMINION BANK (TD, TDBCP) — $21.4M
Recent NGNE insider trades
- Jul 7, 2026: Cvijic Christine Mikail sold 4,800 shares ($173K)
- Jul 2, 2026: Cvijic Christine Mikail sold 4,800 shares ($167K)
- May 6, 2026: Cvijic Christine Mikail sold 9,600 shares ($300K)
- Mar 26, 2026: Cvijic Christine Mikail sold 2,558 shares ($55.3K)
5%+ owners
- PRUDENTIAL FINANCIAL INC: 11.2% (Schedule 13G, filed Oct 7, 2026)
- Jennison Associates LLC: 11.1% (Schedule 13G, filed Oct 6, 2026)
- Redmile Group, LLC: 9.9% (Schedule 13G/A, filed Aug 14, 2026)
- BALYASNY ASSET MANAGEMENT L.P.: 5.2% (Schedule 13G, filed Aug 14, 2026)